Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy

BACKGROUND. Neutrophil‐lymphocyte ratio (NLR) is a measure of systemic inflammation that appears prognostic in localized and advanced non‐small cell lung cancer (NSCLC). Increased systemic inflammation portends a poorer prognosis in cancer patients. We hypothesized that low NLR at diagnosis is assoc...

詳細記述

保存先:
書誌詳細
出版年:Oncologist
主要な著者: Scilla, Katherine A., Bentzen, Søren M., Lam, Vincent K., Mohindra, Pranshu, Nichols, Elizabeth M., Vyfhuis, Melissa A., Bhooshan, Neha, Feigenberg, Steven J., Edelman, Martin J., Feliciano, Josephine L.
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2017
主題:
Lung Cancer
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469587/
https://ncbi.nlm.nih.gov/pubmed/28533476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0443
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料